Advanced search
Publication Cover
Platelets Volume 26, 2015 - Issue 1
Submit an article Journal homepage
482
Views
13
CrossRef citations to date
0
Altmetric
Short Communications

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia

Tomás José González-LópezServicio de Hematología, Hospital Universitario de Burgos, Burgos, Spain,
,
Blanca Sánchez-GonzálezServicio de Hematología, Hospital del Mar, Barcelona, Spain,
,
Cristina PascualServicio de Hematología, Hospital Gregorio Marañón, Madrid, Spain,
,
Maryam ArefiServicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain,
,
Erik de CaboServicio de Hematología, Hospital del Bierzo, Ponferrada, León, Spain,
,
Arancha AlonsoServicio de Hematología, Hospital Universitario Quirón Madrid, Madrid, Spain,
,
Mónica Martín-SalcesServicio de Hematología, Hospital Universitario La Paz-IDIPaz, Madrid, Spain,
,
Reyes Jiménez-BárcenasServicio de Hematología, Hospital Universitario Virgen del Rocío, Sevilla, Spain,
,
María CalbachoServicio de Hematología, Hospital Ramón y Cajal, Madrid, Spain,
,
Pilar GalanServicio de Hematología, Hospital Mateu Orfilia de Mahón, Mahon, Balearic Islands, Spain,
,
Abelardo BarezServicio de Hematología, Complejo Asistencial de Ávila, Ávila, Spain, and
&
José Ramón González-PorrasServicio de Hematología, Hospital Universitario de Salamanca – IBSAL, Salamanca, SpainCorrespondence[email protected]
 show all
Pages 83-86 | Received 27 Sep 2013, Accepted 27 Nov 2013, Published online: 05 Feb 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Adele Barlassina, Tomás José González-López, Nichola Cooper & Francesco Zaja. (2023) European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopenia. Platelets 34:1.
Read now
Abdulgabar Salama. (2017) Emerging drugs for immune thrombocytopenia (ITP). Expert Opinion on Emerging Drugs 22:1, pages 27-38.
Read now

Articles from other publishers (11)

Zhifa Wang, Lijuan Wang, Yan Liu, Jinxi Meng, Shuyue Dong, Jingyao Ma, Yu Hu, Zhenping Chen, Xiaoling Cheng & Runhui Wu. (2023) Sustained response off treatment in eltrombopag for children with persistent/chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China. British Journal of Haematology 202:2, pages 422-428.
Crossref
Drew Provan & John W. Semple. (2022) Recent advances in the mechanisms and treatment of immune thrombocytopenia. eBioMedicine 76, pages 103820.
Crossref
Maria L. Lozano, Cristina Segú-Vergés, Mireia Coma, María T. Álvarez-Roman, José R. González-Porras, Laura Gutiérrez, David Valcárcel & Nora Butta. (2021) Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach. International Journal of Molecular Sciences 22:13, pages 6907.
Crossref
Nichola Cooper, Quentin A. Hill, John Grainger, John-Paul Westwood, Charlotte Bradbury, Drew Provan, Jecko Thachil, Nicholas Ramscar & Anuja Roy. (2021) Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel. Acta Haematologica 144:4, pages 418-426.
Crossref
James Bussel, Austin Kulasekararaj, Nichola Cooper, Amit Verma, Ulrich Steidl, John W. Semple & Britta Will. (2019) Mechanisms and therapeutic prospects of thrombopoietin receptor agonists. Seminars in Hematology 56:4, pages 262-278.
Crossref
David Gómez-Almaguer. (2018) Eltrombopag-based combination treatment for immune thrombocytopenia. Therapeutic Advances in Hematology 9:10, pages 309-317.
Crossref
Adam Cuker. (2018) Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practices. American Journal of Hematology 93:6, pages 816-823.
Crossref
Clémentine Estève, Maxime Samson, Alexandre Guilhem, Barbara Nicolas, Vanessa Leguy-Seguin, Sabine Berthier, Bernard Bonnotte & Sylvain Audia. (2017) Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients. PLOS ONE 12:10, pages e0187296.
Crossref
Sunil Lakhwani, María Perera, Fernando Fernández‐Fuertes, Mario A. Ríos de Paz, Melisa Torres, José María Raya & Miguel T. Hernández. (2017) Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres. European Journal of Haematology 99:4, pages 372-377.
Crossref
Harinder Gill, Raymond S. M. Wong & Yok-Lam Kwong. (2017) From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag. Therapeutic Advances in Hematology 8:5, pages 159-174.
Crossref
Tomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, Blanca Sánchez-González, Fernando Fernández-Fuentes, Isidro Jarque, Gloria Pérez-Rus, Susana Pérez-Crespo, Silvia Bernat, José Angel Hernández-Rivas, Marcio M. Andrade, Montserrat Cortés, Marta Gómez-Nuñez, Pavel Olivera, Violeta Martínez-Robles, Angeles Fernández-Rodríguez, Miguel Angel Fuertes-Palacio, Carmen Fernández-Miñano, Erik de Cabo, Rosa Fisac, Carlos Aguilar, Abelardo Bárez, María Jesús Peñarrubia, Luis Javier García-Frade & José Ramón González-Porras. (2016) Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice. European Journal of Haematology 97:3, pages 297-302.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.